PRKAA2 and lung cancer: Another report indicated that circHIPK3 played an oncogenic role in lung cancer and acted as a pivotal autophagy controller via miR-124-3p/STAT3/PRKAA axis, and its potential of being prognosis biomarker and treatment target for lung cancer was confirmed as well [12].